Vycor Medical INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
OQB
Vycor Medical, Inc. announced financial results for the three and six months ended June 30, 2026, showing a decrease in revenue and operating profit for its Vycor Medical division.
OQB
Vycor Medical reports a 5% revenue increase and improved operating profitability for the first quarter of 2026.
OQB
Vycor Medical, Inc. announced its financial results for the year ended December 31, 2025, reporting an 18% increase in Vycor Medical division revenues and a return to operating profit.
OQB
Vycor Medical, Inc. announced significant revenue growth and a return to operating profit for the three and nine months ended September 30, 2025, driven by its Vycor Medical division.
OQB
Vycor Medical announced significant revenue and operating profit increases for Q2 2025, driven by international expansion of its neurosurgery division.
OQB
Vycor Medical announces a 30% increase in revenue for the first quarter of 2025, primarily driven by international sales growth in its Vycor Medical division.
OQB
Vycor Medical, Inc. announces its financial results for the year ended December 31, 2024, highlighting a 9% increase in revenue driven by growth in its Vycor Medical division.